Researching the watershed-scale spatiotemporal groundwater and surface water mixing function, groundwater recharge heights and age can provide important information to watershed water sources management and water pollution controlling. In this study, 20 groundwater samples, 6 precipitation samples, and 40 surface water samples in the Yiluo River watershed in middle China were collected, and the mixing function between groundwater and surface water, recharge height, and age of groundwater was studied by using hydrochemistry (Cl, DO, EC, pH), radioactive isotopes (14C), and stable isotopes (13C, 18O, 15N). https://www.selleckchem.com/products/ag-1024-tyrphostin.html The results showed that river and shallow groundwater had frequent interaction. Evaporation function played a major role in the groundwater recharging process. Groundwater age displayed spatial and seasonal variations, and the age ranged from 660 to 2800 years (dry season) and 560 to 1800 years (wet season) in downstream and midstream, while the age range from 12,025 to 143,600 years (dry season) and 10,560 to 12,650 years (wet season) in upstream. The average recharge height of downstream and midstream both in dry and wet seasons is about 576.00 to 908.70 m. While in upstream, both, in the dry and wet seasons, ranged from 1285 to 2680 m. The mixing function between groundwater and surface water displayed spatiotemporal variety. These results of this study can provide useful information for the watershed-scale water resources management.Recently, nanocomposite photocatalysts based on semiconductors have drawn consideration due to their suitable bandgap. Combination of tow of several semiconductors can slow down the electron-hole recombination. For this purpose, we have introduced DyMnO3/Fe2O3 nanocomposite as a novel and efficient catalyst for water purification. For this regard, DyMnO3/Fe2O3 nanocomposite has been fabricated by a simple and green sol-gel auto-combustion technique. The impact of calcination temperature, time, and types of fuel was investigated on morphology, structure, and purity of the products. The samples were identified by XRD, FTIR, FESEM, HRTEM, BET, and DRS. The bandgap was calculated by DRS to be 3.20 and 3.28 eV for Fe2O3 and DyMnO3. Due to the appropriate bandgap, DyMnO3/Fe2O3 degraded 80% of methylene blue under UV light. The future aspects of the DyMnO3/Fe2O3 application can be applied in thermoelectric materials, solid fuel cells, electrochemical gas sensors, and electrochemical biosensors.We aimed to identify the contributing predictors for short stature and pre-shortness in Chinese preschool-aged children, and further to construct nomogram prediction models.
A large cross-sectional, kindergarten-based study was conducted during September-November, 2019 in Beijing. Utilizing a stratified random sampling method, total 20 kindergartens with 7310 children with complete data were eligible for analysis.
The prevalence of short stature and pre-shortness was 3.0% (n?=?222) and 11.6% (n?=?848), respectively. Six contributing predictors were significantly associated with short stature, including parental height (odds ratio, 95% confidence interval, P 0.773, 0.69-0.86, &lt;0.001), maternal height (0.723, 0.64-0.82, &lt;0.001), birthweight (0.826, 0.74-0.92, 0.001), birth height (0.831, 0.69-1.00, 0.046), children body mass index (1.204, 1.43-1.82, &lt;0.001), and maternal age at menarche (1.614, 1.43-1.82, &lt;0.001). Seven significant contributing predictors were found for pre-shortness, including parental height (0.805, 0.76-0.85, &lt;0.001), maternal height (0.821, 0.77-0.87, &lt;0.001), birthweight (0.881, 0.83-0.93, &lt;0.001), birth height (0.86, 0.78-0.95, 0.003), gestational weight gain (0.851, 0.77-0.94, 0.002), children body mass index (1.142, 1.05-1.24, 0.002), and chronic disease (4.016, 1.66-9.70, 0.002). The nomogram models for short stature and pre-shortness had descent prediction accuracies.
Our findings indicate that short stature is predominantly determined by inherited and natal factors, and pre-shortness is additionally by modifiable factors.
Our findings indicate that short stature is predominantly determined by inherited and natal factors, and pre-shortness is additionally by modifiable factors.Differences in tumor biology, genomic architecture, and health care delivery patterns contribute to the breast cancer mortality gap between White and Black patients in the US. Although this gap has been well documented in previous literature, it remains uncertain how large the actual effect size of race is for different survival outcomes and the four breast cancer subtypes.
We established a breast cancer patient cohort at the University of Chicago Comprehensive Cancer Center. We chose five major survival outcomes to study overall survival, recurrence-free survival, breast-cancer-specific survival, time-to-recurrence and post-recurrence survival. Cox proportional hazards models were used to estimate the hazard ratios between Black and White patients, adjusting for selected patient, tumor, and treatment characteristics, and also stratified by the four breast cancer subtypes.
The study included 2795 stage I-III breast cancer patients (54% White and 38% Black). After adjusting for selected patient, tumor and treatment characteristics, Black patients still did worse than White patients in all five survival outcomes. The racial difference was highest within the HR-/HER2+ subgroup, in both overall survival (hazard ratio?=?4.00, 95% CI 1.47-10.86) and recurrence-free survival (hazard ratio?=?3.00, 95% CI 1.36-6.60), adjusting for age at diagnosis, cancer stage, and comorbidities. There was also a significant racial disparity within the HR+/HER2- group in both overall survival and recurrence-free survival.
Our study confirmed that racial disparity existed between White and Black breast cancer patients in terms of both survival and recurrence, and found that this disparity was largest among HR-/HER2+ and HR+/HER2- patients.
Our study confirmed that racial disparity existed between White and Black breast cancer patients in terms of both survival and recurrence, and found that this disparity was largest among HR-/HER2+ and HR+/HER2- patients.